Live Breaking News & Updates on Ocugen

Stay informed with the latest breaking news from Ocugen on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Ocugen and stay connected to the pulse of your community

National News: Ocugen files Covaxin IND application with USFDA, seeks nod for Phase-3 trial in US | India News – Rashtra News

Ocugen files Covaxin IND application with USFDA, seeks nod for Phase-3 trial in US | India News - Rashtra News : Rashtra News #Ocugen #files #Covaxin #IND #application #USFDA #seeks #nod #Phase3 #trial #India #News #Times #India HYDERABAD: Ocugen Inc, Bharat Biotech’s US and Canada partner for indigenously developed Covid-19 vaccine Covaxin, has submitted an

India , United-states , Hyderabad , Andhra-pradesh , Canada , Bharat , American , Shankar-musunuri , Ocugen-inc , Drug-administration , India-news , Rashtra-news

Ocugen (NASDAQ:OCGN) Hits New 52-Week High at $1.98

Ocugen, Inc. (NASDAQ:OCGN – Get Free Report)’s share price reached a new 52-week high during trading on Monday . The company traded as high as $1.98 and last traded at $1.97, with a volume of 10300270 shares changing hands. The stock had previously closed at $1.64. Wall Street Analysts Forecast Growth Separately, HC Wainwright reaffirmed […]

Ocugen-inc , Belpointe-asset-management , Schonfeld-strategic-advisors , Ocugen-company-profile , Lazard-asset-management , Sigma-securities , Nasdaq , Get-free-report , Asset-management , Strategic-advisors , Ocugen-daily

Ocugen (NASDAQ:OCGN) Reaches New 1-Year High at $1.98

Ocugen, Inc. (NASDAQ:OCGN – Get Free Report) shares hit a new 52-week high during trading on Monday . The stock traded as high as $1.98 and last traded at $1.97, with a volume of 10300270 shares traded. The stock had previously closed at $1.64. Analysts Set New Price Targets Separately, HC Wainwright reaffirmed a “buy” […]

Ocugen-company-profile , Sigma-securities , Lazard-asset-management , Nasdaq , Ocugen-inc , Belpointe-asset-management , Schonfeld-strategic-advisors , Get-free-report , Asset-management , Strategic-advisors , Ocugen-daily

Ocugen (NASDAQ:OCGN) PT Raised to $7.00

Ocugen (NASDAQ:OCGN – Get Free Report) had its price target upped by equities researchers at HC Wainwright from $5.00 to $7.00 in a research note issued on Wednesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. HC Wainwright also issued estimates for Ocugen’s FY2024 earnings at ($0.25) EPS, FY2025 earnings at […]

Lazard-asset-management , Sigma-securities , Belpointe-asset-management , Schonfeld-strategic-advisors , Ocugen-inc , Get-free-report , Trading-down , Asset-management , Strategic-advisors , Ocugen-daily , Ocugen

Ocugen (NASDAQ:OCGN) Trading 1.8% Higher

Ocugen, Inc. (NASDAQ:OCGN – Get Free Report) rose 1.8% during mid-day trading on Monday . The company traded as high as $0.60 and last traded at $0.58. Approximately 5,906,200 shares were traded during trading, an increase of 18% from the average daily volume of 5,020,522 shares. The stock had previously closed at $0.56. Ocugen Price […]

Belpointe-asset-management , Sigma-securities , Ocugen-inc , Schonfeld-strategic-advisors , Nasdaq , Lazard-asset-management , Get-free-report , Asset-management , Strategic-advisors , Ocugen-daily , Ocugen

Ocugen (NASDAQ:OCGN) Stock Price Down 1.6%

Ocugen, Inc. (NASDAQ:OCGN – Get Free Report) dropped 1.6% on Tuesday . The company traded as low as $0.43 and last traded at $0.43. Approximately 1,235,873 shares changed hands during trading, a decline of 79% from the average daily volume of 5,761,433 shares. The stock had previously closed at $0.43. Analysts Set New Price Targets […]

Nasdaq , Advisor-group-holdings-inc , Mackenzie-financial-corp , Wealth-management , Ocugen-company-profile , Schonfeld-strategic-advisors , Cantor-fitzgerald , Sigma-securities , Ocugen-inc , Get-free-report , Trading-down

Ocugen Shares Rise 9% After OCU500 Inclusion in NIAID Trial

By Chris Wack Ocugen shares were up 9% at 45 cents after the company said the National Institute of Allergy and Infectious Diseases, a part of the National...

Chris-wack , National-institutes-of-health , National-institute-of-allergy , National-institute , Infectious-diseases , National-institutes , Article-normal , Biotechnology-services , Pharmaceuticals , Vaccines , Healthcare-life-sciences , Specialized-drugs-medications

Ocugen (NASDAQ:OCGN) Earns "Buy" Rating from HC Wainwright

HC Wainwright reissued their buy rating on shares of Ocugen (NASDAQ:OCGN – Free Report) in a report published on Wednesday, Benzinga reports. HC Wainwright currently has a $5.00 price target on the stock. HC Wainwright also issued estimates for Ocugen’s Q3 2023 earnings at ($0.07) EPS, FY2023 earnings at ($0.31) EPS, Q2 2024 earnings at […]

United-states , America , Junge-zhang , Ocugen-company-profile , Ocugen-inc , Securities-exchange-commission , America-corp , Luminus-management , Renaissance-technologies , Free-report , Chardan-capital , Get-free-report

HC Wainwright Reiterates Buy Rating for Ocugen (NASDAQ:OCGN)

Ocugen (NASDAQ:OCGN – Get Free Report)‘s stock had its “buy” rating reaffirmed by HC Wainwright in a research note issued to investors on Wednesday, Benzinga reports. They presently have a $5.00 target price on the stock. Separately, Chardan Capital lifted their price target on Ocugen from $3.50 to $4.00 in a report on Sunday, May […]

Junge-zhang , Mackenzie-financial-corp , Ocugen-inc , Raymond-james-financial-services-advisors-inc , Wealth-management , Get-free-report , Chardan-capital , Director-junge-zhang , Financial-corp , James-financial-services-advisors , Investment-advisers , Ocugen-daily

Ocugen (NASDAQ:OCGN) Issues Earnings Results

Ocugen (NASDAQ:OCGN – Get Free Report) released its quarterly earnings results on Tuesday. The company reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.07) by ($0.03), MarketWatch Earnings reports. Ocugen Stock Up 16.8 % Shares of NASDAQ OCGN opened at $0.47 on Thursday. The firm’s 50 day moving average price is $0.54 […]

Junge-zhang , Blackrock-inc , Securities-exchange-commission , Ocugen-company-profile , Vanguard-group-inc , Jpmorgan-chase-co , Geode-capital-management , Ocugen-inc , Get-free-report , Marketwatch-earnings , Director-junge-zhang , Exchange-commission